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 MALDI mass spectrometry imaging (MALDI MSI) is a rapidly growing method in 
biomedical research allowing molecular mapping of proteins on histological sections. The 
images can be analyzed in terms of spectral pattern to define regions of interest. However, 
the identification and the differential quantitative analysis of proteins require off line or in 
situ proteomic methods using enzymatic digestion. The rapid identification of biomarkers 
holds great promise for diagnostic research but the major obstacle is the absence of rapid 
and direct method to detect and identify with a sufficient dynamic range a set of specific 
biomarkers. In the current work, we present a proof of concept for a method allowing 
identifying simultaneously a set of selected biomarkers on histological slices with minimal 
sample treatment using in-source decay (ISD) MSI and MALDI-Fourier transform ion 
cyclotron resonance (FTICR). In the proposed method, known biomarkers are spotted next to 
the tissue of interest, the whole MALDI plate being coated with 1,5-DAN matrix. The latter 
enhances MALDI radical-induced ISD, providing large tags of the amino acid sequences. 
Comparative analysis of ISD fragments between the reference spots and the specimen in 
imaging mode allows for unambiguous identification of the selected biomarker while 
preserving full spatial resolution. Moreover, the high resolution/high mass accuracy 
provided by FTICR mass spectrometry allows the identification of proteins. Well-resolved 
peaks and precise measurements of masses and mass differences allow the construction of 
reliable sequence tags for proteins identification. The method will allow the use MALDI-
FTICR MSI as method for rapid targeted biomarker detection in complement to classical 
histology.  
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 Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) is a 
powerful method to reveal the two-dimensional spatial distribution of molecules in tissue 
sections. Essentially, a laser beam irradiates pixel-wise positions on the sample coated with a 
specific matrix
1











 distribution can readily be 
obtained. MALDI-MSI can therefore be considered as an emerging method to complement 
diverse histological staining or immunohistochemistry (IHC). In particularly the IHC is the 
building pillar of every clinical pathology laboratory, allowing for correlation of protein 
expression with histological features and is commonly used to detect clinically relevant 
biomarkers. Unfortunately, the methodology involves many sample preparation steps at 
which uncertainty can be introduced. In addition, each biomarker requires an antibody that 
can lead to unspecific reactions. MALDI MSI brings the advantage of preserving the 
histological information but the mass spectrum has a severe limitation in useful mass range 
when special detectors are not used. 
 Although MALDI-MSI methodology seems appropriate for protein biomarker studies as 
illustrated in previous works
11-13
, the main obstacle remains however the limited 
applicability for in situ protein identification. The classical proteomics identification methods 
namely bottom-up and top-down approaches have been employed in situ to identify 
proteins by MALDI MSI. Bottom-up proteomics is most commonly used, involving enzymatic 
protein cleavage using enzymes such as trypsin. Digested peptides are then analyzed by 
MALDI PMF (peptide mass fingerprint) or MS/MS sequencing
14,15
. In the top-down approach, 
activation techniques (usually ETD and ECD) are used to fragment ions from intact proteins 
and hence provide sequence information
16
. One of the activation techniques particularly 
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suitable for MALDI instruments is the in-source decay (ISD)
17-19
. ISD occurs in the hot MALDI 
plume under a laser power 5-20% above analytes ionization threshold, leading to 
intermolecular transfer of hydrogen atoms between excited matrix molecules and carbonyl 
oxygen on the protein backbone
17,20,21
. The backbone is cleaved at N–Cαbond, producing 
c/(z+1) fragment pairs. The (z+1) radicals undergo either gain of a hydrogen to form (z+2) or 
react with a matrix molecule
22
. Cα–C bonds cleavage can also be observed during MALDI-ISD 
fragmentation initiated by hydrogen abstraction, generating a- and x-seriesions
23,24
. This 
particular fragmentation yields a long series of peaks allowing for N- and C-terminal protein 
sequencing and reliable identification. MALDI-ISD is therefore often referred to as an 
alternative to Edman sequencing
19,25-27
. MALDI-ISD can be used within tissue sections
28,29
 but 
the spectra become rapidly very difficult to analyze even when additional confirmation of 





. Using FTICR analyzers provides higher resolution and 
mass accuracy measurement compared to TOF analyzers and brings better sequence tags for 
the identification and the localization of proteins by MALDI-ISD MSI
34
. 
 If the in situ identification of unknown proteins is very challenging, the detection of 
targeted proteins could be easier, knowing the sequence to be searched. In the current 
work, we present a proof of concept of a rapid targeted in situ method for the detection of 
selected biomarkers directly on histological slides, using MALDI-ISD MSI with a FTICR mass 
spectrometer. The method relies on the analogy of series of peaks between the sample and 
spots of the pure target proteins deposited in the sample vicinity. As the method is based on 
direct comparison of the MS spectra, it eliminates the need for complex computational 
software. To assess the validity of this approach various hypotheses had first to be verified. 
The first assumes that the ISD fragmentation patterns are the same when proteins are 
Page 4 of 31






























































deposited pure on a MALDI spot or localized in a tissue. The detection of peptide ions both 
in the pure protein spot and in the tissue sample by FTICR MS allowed to identify peaks 
belonging to the same fragmentation series presenting the same localization on images and 
led to an unambiguous identification of the original protein. The applicability of the method 
had then to be proven on protein mixtures. Finally, the method had to be applied on both 
frozen and paraffin embedded tissue sections. We show here that the proposed strategy 
allows detecting the presence of peptide/protein directly on histological tissue sections, 
opening new perspectives for the use of MALDI MSI for multiple biomarkers detection in 
pathology analysis.  
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 Purified matrix 1,5-diaminonaphthalene (1,5-DAN) and 1,1,1,3,3,3-Hexafluoro-2-
propanol (Hexa Fluoro Iso Propanol, HFIP) were purchased from Sigma-Aldrich, Saint Louis, 
MO. 
 
Peptide and proteins 
 Ubiquitin from bovine erythrocytes (Mr 8565 Da), α-crystallin from bovine eye lens (Mr 
19778 Da), Bovine Serum Albumin (BSA, Mr 67161 Da), Human Serum Albumin (HSA, Mr 
69321), MBP from mouse (MBP, Mr 14113 Da), β-casein from bovine milk (Mr 23568 Da), 
lysozyme from chicken egg (Mr 16228), myoglobin from equine heart (Mr 17072), 
cytochrome c from equine heart (Mr 11811), insulin from porcine pancreas (Mr 11664), β-
lactoglobulin from bovine milk (Mr 19870) and HNP-1 (Mr3439.5 Da) were purchased from 
Sigma-Aldrich, Saint Louis, MO. All proteins solution were prepared at a concentration of 10 
mg/ml in 0.1% Trifluoroacetic Acid (TFA). 
 
Tissues 
Harvesting of Tissues 
 A 6-months-old Balb C mouse was provided by the Central Animal Housing of Liège 
University. During intraperitoneal anesthesia with 60 mg/kg pentobarbital, mouse was 
dissected to extract the brain which was snap frozen by immersion in pre-cooled isopentane 
at -80°C for 1 min. Brain was kept at -80°C until required. 
 Eyes coming from pigs aged from 18 to 24 weeks were purchased from the 
slaughterhouse of Aubel (Detry S.A, Belgium). The eyes were dissected immediately after 
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harvesting to extract the lenses which were frozen on powdered dry ice for 5 min. Eye lenses 
were kept at -80°C until required. 
 Fresh liver metastasis tissue was collected from a 63-years-old female patient at the 
time of surgery. The patient was resected for rectal adenocarcinoma and associated liver 
metastasis at the same time, and had no treatment before the resection. The original 
primary tumor was poorly differentiated (grade 3) with nodal infiltrations. The primary 
tumor was K-Ras mutated. Sampled liver tissue was fixed overnight in paraformaldehyde 
solution (4%) and included in paraffin block. 
 All further tissue manipulations were done on dry ice to minimize the possibility of 
localized tissue warming. 
 
Tissues Preparation 
 Mouse brain was placed at -25°C 1 h before use. Tissue sections were prepared on a 
Microm HM 500 O (Microm, Heidelberg, Germany) with the microtome chamber chilled at -
25°C and the specimen holder at -23°C. 14μm thick coronal sections at Interaural 9.70 mm 
and Bregma 0.70 mm have been realized and thaw mounted onto ITO-coated microscopic 
slides (Bruker Daltonics, Bremen, Germany) adapted for MALDI mass spectrometry. 
Following thaw mounting of tissue sections, MALDI target slides were allowed to dry for 1 h 
in a desiccator. 
 Porcine eye lens were placed at -25°C 1 h before use. 18μm thick equatorial sections 
have been realized, thaw mounted onto ITO-coated microscopic slides and dried for 1 h in a 
dessiccator. 
 Liver tissue was sectioned at 10 µm thickness and placed on ITO conductive slides. Prior 
to MALDI-imaging analysis, the tissue was subjected to de-paraffination step in xylene bath 
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followed by methanol baths of decreasing concentration (100% - 50%). Next, the tissue was 
subjected to antigen retrieval step conducted in citrate buffer (10mM Citric Acid, 0.05% 
Tween 20, pH 6.0) bath at 95°C for 30 min. Finally, the slide was air-dried and coated with 
MALDI matrix. 
 Then, mouse, porcine eye lens and liver tissue sections were washed six times using the 
following protocol previously described
35
: 70% ethanol, 100% ethanol, Carnoy’s fluid (60% 
ethanol, 30% chloroform, and 10% acetic acid), 100% ethanol, H2O, 100% ethanol. All rinse 
steps were carried out for 30 s except for the step with Carnoy’s solution, which was for 2 
min. Following washing, ITO slides were dried in a desiccator for 1 h before matrix 
deposition. Finally, 3 µL of MBP, α-crystallin or HNP-1 solutions (1 mg/ml in 0.1 % TFA) were 
spotted near mouse brain, porcine eye lens or normal/diseased liver sections and allowed to 
dry under vacuum for 10 min. 
 
Protein spots preparation for MALDI-ISD MSI experiments 
 For the first MALDI-ISD MSI experiments on protein spots, 1pmol of β-casein, MBP, 
ubiquitin, BSA and α-crystallin were deposited on ITO-coated microscopic slides. Then, 2 
pmol of each protein solution were mixed and deposited on the same ITO-coated 
microscopic slides. For the second experiments, 1 pmol of β-casein, MBP, ubiquitin, BSA and 
α-crystallin were deposited on a ITO-coated microscopic slides. Then, 2 pmol of MBP, BSA 
and α-crystallin, 1 pmol of ubiquitin and 0.2 pmol of β-casein were mixed and deposited on 
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Protein mixture spots preparation for MALDI-ISD experiments 
 Spots of 1pmol of β-casein, MBP, ubiquitin, HSA, lysozyme, myoglobin, cytochrome c, 
insulin, β-lactoglobulin and α-crystallin were deposited on the same ITO-coated microscopic 
slides. Spots were then allowed to dry under vacuum for 10 min. 
 
Matrix deposition for protein solutions and tissue MSI 
 1,5-DAN matrix was used for all experiments. For MALDI-ISD imaging, other MALDI 
matrices (2,5-dihydroxybenzoic acid, 2-Aminobenzamide and 2-aminobenzoic acid) were 
tested and does not allowed to obtain intense ISD fragments ions as observed with 1,5-DAN 
(data not shown). For all the experiments, 1,5-DAN matrix (6 mg/mL solution in ACN/0.2% 
TFA 70:30 vol/vol) deposition was performed with an ImagePrep automated sprayer device 




HFIP treatment and matrix deposition for MALDI-ISD analyzes of protein mixture spots and 
mouse brain tissue sections 
 For on tissue and protein spot solvent-based protein extraction, 10 µL of pure HFIP 
solution was manually dropped following a procedure adapted from Longuespée et al.
36
. For 
tissue sections, a first volume of 2 µL of HFIP was deposited in order to condition the protein 
tissular environment to the highly hydrophobic solvent HFIP. For protein extraction on tissue 
and protein spot, four droplets of 2 µL of HFIP were deposited, each followed by up and 
down manual pipetting. After the drying of the preparation, a droplet of 1,5-DAN (6 mg/mL 
solution in ACN/0.2% TFA 70:30 vol/vol) was deposited on the prepared area. The volume of 
this last droplet is adapted in function to the size of the area to analyze. 
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MALDI-FTICR mass spectrometry 
 Mass spectra were acquired using a SolariX FTMS (9.4 T) equipped with a ESI/MALDI 
Dual Ion Source including smartbeam
TM
II laser (wavelength, 355 nm; focus setting, 
‘minimum’; repetition rate, 1000 Hz). MALDI MSI experiments were acquired with a pixel 
step size for the surface raster set to 150 µm in FlexImaging 3.0 software. Spectra were 
externally calibrated using a peptide mix calibration standard. For MALDI-ISD MSI and 
MALDI-ISD analyzes, spectra were acquired in positive ion mode from 120 and 4000 laser 
shots accumulated at each spot, respectively. The laser intensity was set to 20% with a 
frequency of 150 Hz. Q1 mass was fixed at m/z 750 and m/z 350 for protein spots and tissue 
sections analyzes, respectively. Ion cooling time and time of flight values were set to 0.02 s 
and 7 ms, respectively. 
 For each protein fragmented by MALDI-ISD, monoisotopic masses of an acquired 
spectrum selected from FlexImaging 3.0 were labelled using DataAnalysis 4.0 with the SNAP 
peak-picking algorithm and exported in .bsc format. Spectra in .bsc format were then 
permanently assigned as ISD-type in BioTools 3.2 software. A default approach was used to 
assign peaks with a mass tolerance comprised between 3 and 6 ppm. For all proteins, the 
sequence was transferred from Sequence Editor 3.2 and sequence tags were automatically 
determined and annotated on the spectrum. Results were interpreted in combination with a 
local intranet Mascot
TM
 (Matrix Science, London) server. For top-down sequencing 
searching, the “virtual precursor” approach has been used. A high mass c ion is automatically 
selected as virtual precursor for the MS/MS ion search. 1 Da is added to the mass of the c ion 
for database searching. All MALDI-ISD spectra were searched against the NCBI-nr database. 
No enzyme cleavage was specified and protein N-terminus acetylation, or more of the 
following modification were set as variable: lysine acetylation and serine/threonine 
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phosphorylation. Charge state of +1 were considered for parent ions. Mass tolerance was set 
to 0.1 % for parent ion masses and ±0.1 Da for fragment ion masses. Identification of 
proteins were validated for a Mascot score of 30 or above.  
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RESULTS AND DISCUSSION 
 In situ identification of proteins on tissue sections requires either their localized 
extraction or their digestion with enzymes, conducing to a loss of lateral resolution. MS/MS 
is required to sequence the peptides but is difficult to perform due to the large number of 
peaks making very difficult the precursor selection. Unsupervised image analysis is still time 
consuming and brings only the definition of regions of interest. When looking for the 
presence of target proteins for biomarkers detection in tissue slices, a faster and simpler 
protocol would be helpful to improve the throughput. In situ protein identification by 
MALDI-ISD does not require treating tissue sections
29
. However, in the current workflow, the 
identification of proteins from mixtures by MALDI-ISD still requires MS/MS sequencing of an 




. This last step is generally easy to perform from ISD 
fragments of pure proteins but is difficult in complex samples. In the proposed strategy, we 
assign fragments by comparison with series of peaks observed in the spectra of spots of pure 
target proteins deposited besides the tissue section. In addition, we use localization 
information of fragments to reconstitute series belonging to the same protein. The presence 
of a fragment in an area of the sample as well as in the spot of a target protein simplifies the 
analysis of the complex spectra in targeted analysis mode. We hope, with that strategy, to 
increase the dynamic range and speed-up the image analysis. 
To develop this method, the following questions should first find answers: 
1 Can MALDI-ISD MSI detect in situ a target protein finding a sequence tag similar to 
that obtained for the spot of pure proteins? 
2 Can MALDI-FTICR ISD be used to directly identify several proteins in a tissue 
section? 
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1 Can MALDI-ISD MSI detect in situ a target protein finding a sequence tag similar to 
that obtained for the spot of pure proteins? 
 Here we show on a model system that FTICR MS allows identifying proteins by MALDI-
ISD MSI by the comparison with peaks obtained from a pure protein spot. Figure 1 shows a 
MALDI-ISD MSI experiment performed on pure MBP and α-crystallin solutions spots. As 
evidenced in Figure 1A, it is possible to assign specifically ISD fragment ion peaks of each 
protein deposited from synthetic solutions. Identification by ISD can be obtained, by 
comparison between ISD ion images of a given protein. As shown on upper panels of Figure 




c16 ions images of α-crystallin 
(blue spots) are identical and confirm the identification. MS/MS from an intense ISD 
fragment is therefore not required anymore for a reliable identification. In the latter, the 
protein can be identified by Mascot search from a mass spectrum selected from a pixel with 
maximum intensity (identifications with a score of 1021 for MBP and of 312 for α-crystallin 
in Figure 1B, respectively). 
 The same experiment was performed on histological tissue sections to find correlations 
between the ISD ion images. The “co-localization of fragments and MALDI-ISD profile 
matching” is interesting to qualitatively detect in a tissue section a set of peak belonging to 
the same protein as the one spotted near the tissue. For example, a MALDI-ISD MSI 
experiment was performed on a horizontal mouse brain section and on a pure MBP solution 
spot filled near the tissue section (Figure 2A). A signal, both within the white matter of the 
central nervous system where is localized this protein and the MBP spot, is observed in the 
c15 ion image (upper right panel of Figure 2A) and signal is correlated with hematoxylin and 
eosin (H/E) staining (upper left panel of Figure 2A). As shown in Figure S2, all the selected 
ISD ions of the MBP (c10, c15and c19) triggers the same signal both within the white matter of 
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the central nervous system where is localized this protein and the MBP spot. Mascot 
searches results for a mass spectrum selected from a pixel with maximum intensity 
confirmed the identification of the MBP with a score of 1002 (Figure 2A and S1A). 
Alternatively, a list of peaks taken from the tissue and similar to peaks in the reference spot 
can confirm the identification using database search. We performed the same experiment 
on a porcine eye lens section and a spot of αA/B-crystallin solution (Figure S3). A signal is 
simultaneously observed on the ion images of the cn ISD ions of the αA- (data not shown) 
and αB-crystallin (c11 ion for example, Figure S3) isotypes, both in the tissue section and the 
αA/B-crystallin spot. On the contrary, no signal is observed for the αA/B-crystallin spot on 
the ion images of the cn ISD ions of the γ-crystallin (c14 ion as example, Figure S3). As 
previously presented by Han et al., same localization of the crystallin isotypes is observed
37
. 
Ion images of c11 ion of αB-crystallin and c14 ion of γ-crystallin is correlated with H/E staining 
image (Figure S3A). αB-crystallin is localized in the periphery of the eye lens whereas γ-
crystallin is in the central part. Mascot searches results for mass spectra selected from pixels 
with maximum intensity confirmed the identification of the αA/B-crystallin and γ-crystallin 
isotypes with scores of 123 and 91, respectively (Figure S3). We demonstrated here that it is 
possible to identify isotypes of a given protein and observe their expression within a tissue 
section without any doubt. 
 To consider if this approach could complement histopathology analysis based on native 
molecular signatures in tumors and the surrounding tissues, we applied it to identify 
unambiguously a known tumor necrosis biomarker, HNP-1. HNP-1 is a peptide that belongs 
to the α-defensin family. It is synthesized in neutrophil precursor cells and is released by 
mature circulating neutrophils at inflammatory sites
38-40
. Several studies have shown that 




 in cancer cells like renal cell 
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 but also oral squamous cell carcinoma or colorectal cancer
43
 and is associated 
with tumor growth and proliferation. Another study led by MALDI MSI has indicated that 
HNP-1 is mostly expressed in the necrotic tissue area of cancer tissue so that it can be 
assimilated as a tumor necrosis biomarker
45
. Figure 2B shows a MALDI-ISD MSI experiment 
performed on a liver tissue section of a patient with colorectal cancer liver metastasis and 
two spots of HNP-1 (positive control) and MBP (negative control) solutions. In the same way, 
a signal is observed for both the necrotic core of the liver tissue section and the spot of HNP-
1 for c7, c10 and c13 ISD ions (upper right panel of Figure 2B and Figure S4A). These results are 
entirely consistent with a H/E staining previously done on this tissue section (upper left 
panel of Figure 2B) and a Mascot searches result for a mass spectrum selected from a pixel 
with maximum intensity in the necrotic core that confirmed the identification of HNP-1 with 
scores of 1581 (lower panel of Figure 2B and Figure S1B). On the contrary, as expected, 
signals for the c8, c14 and c17 ISD ions of the MBP (negative control) are not observed in the 
tissue section (Figure S4B). 
 As shown in of Figure S3, this highlights that this approach could be used for targeted 
analysis of known biomarkers. For that purpose, it is essential that several potential 
biomarkers, with an increased dynamic range can be identified by MALDI-ISD. 
 
2 Can MALDI-FTICR ISD be used to directly identify several proteins in a tissue 
section? 
 Figure 3 shows a MALDI-ISD MSI experiment performed on five spots of ubiquitin, α-
crystallin, BSA, MBP and β-casein pure solutions and an additional spot corresponding to an 
equimolar mixture of these proteins (called “the 5-proteins mixture” further in the text). 
According to the signals observed on the ion images of Figure 3 (c11 and (z+2)15 for ubiquitin, 
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c14 and c16 for α-crystallin, c12 and c24 for BSA, c10 and c12 for MBP, and y17 and y19 for β-
casein), it is possible to monitor five proteins by MALDI-FTICR ISD MSI. Moreover, the spots 
of pure protein solutions provide a direct identification, by MALDI-ISD and without MS/MS 
sequencing, of the proteins present in the mixture. For each protein, sequence tags have 
been identified from mass spectra selected from pixels of high intensity (Figure S5) and 
Mascot searches confirmed their identification except for the α-crystallin that present a 
Mascot score under the identity threshold (Figure S6). As shown in Figure S5B, most of the 
ISD peaks of the α-crystallin are slightly above the baseline and can explain this low Mascot 
score. This low yield of ISD fragments can be explained by either fragmentation or ionization 
yield that can be affected by the presence of specific amino acids residues and the 
accessibility for the hydrogen radical
17, 46-49
. A deeper understanding of the ISD process is 
mandatory to fully exploit the method. 
 To determine if the relative protein concentration can favor the ISD fragmentation of 
the α-crystallin, we performed the same experiment with different molar ratios of ubiquitin 
and β-casein 10-times and 2-times lower in the “5-proteins mixture”, respectively (Figure 4). 
According to the signals observed on the ion images of Figure 4 (c20 and (z+2)19 for 
ubiquitin,c14 and c16 for α-crystallin, c10 and c11 for BSA, c8 and c11 for MBP, and y17 and y19 
for β-casein), it is possible to identify five proteins by MALDI-FTICR ISD MSI. MALDI-ISD 
allowed to determine sequence tags of α-crystallin, BSA and MBP from mass spectra 
selected from pixels with maximum intensity for each protein in the “5-proteins mixture” 
(Figure S7) for their identification by Mascot searches (Figure S8). However, no sequence 
tags long enough to allow the identification of ubiquitin and β-casein by Mascot searches 
were found. 
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 A major issue of the top-down ISD for in situ identification is the high dynamic range 
required to detect low abundance proteins. It is now well known that a simple ISD analysis of 
a tissue, without any prior tissue preparation can only give access to the identification of the 
major proteins, then reducing the usefulness of the method
29, 50
. For example, the ISD on 
tissue analysis of brain sections mostly allows the tagging of MBP. Here we describe a 
method that can guide the user to increase the number of proteins identified. However, the 
relative amount of some proteins still remains problematic since only identification of the 
most prevalent proteins can be addressed using this method. This could be detrimental for 
histopathological applications since the amount of some markers of interest, even if 
overexpressed in the pathological context, could have an expression under the most 
prevalent proteins. We then speculate that the use of chemical sample preparation, 
specifically applied to tissue section could allow the identification of protein by MALDI-ISD 
by their extraction and their unmasking at the surface of the tissue section. Then, the 
disadvantage of the low amount of the proteins of interest can be overcome by the 
exposition of these proteins at the surface of the tissue, and the 1,5-DAN matrix. 
Longuespée et al. previously described a method involving the use of the highly hydrophobic 
solvent HFIP that was used for the detection of the C-terminal fragment of Reg-Alpha, which 
was not detected without this specific procedure
36
. They previously revealed that this 
procedure allowed extending the mass range for in situ protein analysis until 70 kDa
51
. We 
then decided to adapt this method to this present issue in order to allow the unmasking of 
the proteins present in tissues. We then deposited this solvent on a mouse brain tissue 
section in separated step in order to condition the tissue to the highly hydrophobic property 
of the solvent and to address the problem of the spreading of the solvent. We speculate that 
the first drop allows the exposition of the most hydrophobic parts of the proteins. The next 
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drops are then necessary to extract these proteins at the surface of the tissue for their 
incorporation in 1,5-DAN matrix crystals. The Figure 5A illustrates the comparison between 
ISD analyzes of serial mouse brain sections with and without prior tissue preparation. This 
shows that the number of peaks is greatly improved using this method (supplementary 
peaks are annotated with red arrows on the lower mass spectrum of Figure 5A). 
Supplementary tags have been determined from these supplementary peaks but only one 
allowed the identification of a protein by MASCOT searches (data not shown). As shown in 
Figure 5B, the hemoglobin has been identified from an ISD fragment tag by MASCOT 
searches. This protein, which is known to be secondly detected in rodent brain sections is 
here detected, exclusively in the context of a HFIP extraction procedure. The same approach 
has been applied on an equimolar mixture of ten proteins (Figure S9). As shown in Figure 5A, 
supplementary ISD ions are detected using the HFIP extraction procedure (supplementary 
peaks are annotated with red arrows on the lower mass spectrum of Figure S9). Moreover, 
MALDI-ISD data acquired with a FTICR MS are sufficiently accurate (mass accuracy 
measurement below 2 ppm) for the identification of the ten proteins based on MASCOT 
searches from ISD fragment tags (Figure S10, S11, S12 and S13). These experiments show 
that some improvements are possible to allow the multiplexed in situ protein identification 
using chemical procedures for on-tissue protein extraction. These chemical procedures could 
then be combined to this presented issue in order to guide the identification of many 
proteins.  
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 MALDI MSI is now a proven new diagnostic tool complementary to histochemistry when 
analyzing molecular signatures to define regions of interest. It can lead to differentiate 
different compartments such as the tumor and the surrounding tissues using spectral 
patterns. MALDI-ISD has proven to be an efficient method for the N- and C-terminal 
sequencing of proteins present in tissue sections and for biomarkers identification. Coupling 
MSI for localization and MALDI-FTICR ISD for identification by comparison with spots of pure 
target proteins could allow a fast-targeted detection and identification of known proteins by 
comparison with side deposited spots of target proteins. These can have been identified by 
any other approach if they are available as a pure protein. Combined with software 
dedicated to protein identification from ISD data, the proposed method can be the basis of a 
new diagnostic tool complementary to histopathology analysis based on native molecular 
signatures in tumors and the surrounding tissues. Further improvements will tend to 
increase the yield of ISD fragmentation of protein present in tissue sections. For this, specific 
treatments such as protein extraction procedure were used here to allow a better exposition 
of the proteins to the matrix crystals and allow the identification of additional proteins. A 
special attention will be devoted to keep intact of the lateral distribution that could be 
affected during the use of solvents.  
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Figure 1.MALDI-FTICR ISD MSI of MBP and α-crystallin pure protein solutions. 
A. Average mass spectrum of a MALDI-FTICR ISD MSI analysis of MBP and α-crystallin spots. 
ISD fragments of each protein are annotated (in red for MBP and blue for α-crystallin) on the 
average mass spectrum. Right inset show isotopic patterns of 
αB
c14 and c16 ions and 
associated imaging signal of αB-crystallin and MBP, respectively. Left inset shows an overlap 
of the ion images corresponding to the c10 ions of MBP (in red) and αA-crystallin (in blue). 
B. ISD mass spectra selected from protein spots with monoisotopically assigned fragment 
ions of MBP (upper spectrum) and α-crystallin (lower spectrum). Insets indicate Mascot 
searches results for both ISD mass spectra. 
 
Figure 2.MALDI-FTICR ISD MSI on tissue sections and pure protein/peptide solutions. 
A. Left upper panel shows an ion image of c15 ISD ion of MBP in a mouse brain tissue section 
and a MBP spot. Right upper panel shows hematoxylin/eosin staining of a serial tissue 
section. Dotted lines delineate the anterior commissure, anterior part (aca), the external 
capsule (ec) and the cingulum (cg). CPu corresponds to the caudate putamen (striatum); ec, 
the external capsule; MS, the medial septal nucleus; Pir, the piriform cortex; E, the 
ependyma and sub ependymal layer. Lower panel corresponds to an ISD mass spectra 
selected from a pixel with maximum intensity (white arrow) with monoisotopically assigned 
fragment ions of MBP. Inset indicates Mascot searches result for this ISD mass spectrum. 
B. Left upper panel shows an ion image of c10 ISD ion of HNP-1 on a liver tissue section with 
colorectal cancer metastasis and two spots of MBP and HNP-1. Right upper panel shows 
hematoxylin/eosin staining of a serial tissue section. Dotted lines delineate necrosis “N” 
area. Lower panel correspond to an ISD mass spectra selected from the necrosis area of the 
liver tissue section (white arrow) with monoisotopically assigned fragment ions of MBP. Inset 
Page 23 of 31






























































indicates Mascot searches result for this ISD mass spectrum. 
 
Figure 3.MALDI-FTICR ISD MSI of an equimolar 5-protein mixture and pure protein 
solutions. 
Ion images correspond to the signal acquired, on an equimolar 5-protein mixture and pure 
protein solutions, for the ISD ions of ubiquitin (c11 and (z+2)15), α-crystallin (c14 and c16), BSA 
(c12 and c24), MBP (c10 and c12) and β-casein (y17 and y19). Numbers indicate the position of 
each pure protein solutions (1: ubiquitin, 2: α-crystallin, 3: BSA, 4: MBP and 5: β-casein). 
 
Figure 4.MALDI-FTICR ISD MSI of a non-equimolar 5-protein mixture and pure protein 
solutions. 
Ion images correspond to the signal acquired, on an equimolar 5-protein mixture and pure 
protein solutions, for the ISD ions of ubiquitin (c20 and (z+2)19), α-crystallin (c14 and c16), BSA 
(c10 and c11), MBP (c8 and c11) and β-casein (y17 and y19). Numbers indicate the position of 
each pure protein solutions (1: ubiquitin, 2: α-crystallin, 3: BSA, 4: MBP and 5: β-casein). 
At the difference of analysis of Figure 3, quantities of ubiquitin and β-casein are respectively 
10-times and 2-times lower in 5-protein mixture for this experiment. 
 
Figure 5. MALDI-FTICR ISD analyzes on mouse brain tissue sections treated or not with 
HFIP. 
A. MALDI-FTICR ISD analyzes of serial mouse brain tissue sections treated (lower mass 
spectrum) or not with HFIP (upper mass spectrum). c and (z+2) on the upper mass spectrum 
correspond to ISD fragments of MBP. Red arrows on the lower mass spectrum indicate peaks 
corresponding to supplementary ISD ions detected after HFIP extraction. 
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B. Upper panel shows ISD mass spectrum with monoisotopically assigned fragment ions of 
hemoglobin. Lower panel corresponds to Mascot search results for hemoglobin 
identification. Sequence coverage of protein termini is indicated in red.  
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